Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
56 participants
INTERVENTIONAL
2014-05-31
2015-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ketamine Reduces Tourniquet Pain In Patients Undergoing Lower Limb Surgery Under Spinal Anaesthesia
NCT03357055
The Effect of Intradermal Local Anesthetic Injection in FBSS (Failed Back Surgery Syndrome)
NCT04268602
The Effect of Intravenous Lidocaine on Pain After Lumbar Spinal Fusion
NCT01319682
Ketamine in Patients Undergoing Anterior Cervical Discectomy and Fusion
NCT02378740
A Preemptive Epidural Ropivacaine for Postoperative Pain Relief in Degenerative Lumbar Spine Surgery
NCT01117610
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Ketamine is categorized as N-methyl D-aspartate receptor antagonist. Ketamine has an analgesic effect in low dose and anesthetic effect in relative high dose. Also, ketamine is used in chronic neuropathic pain as postherpetic neuralgia., phantom pain, central neuropathic pain, complex regional pain syndrome, ischemic pain.
In this study, ketamine will be infused during lumbar surgery in randomized, double-blind and double-blind parallel group control trial.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ketamine
ketamine 0.5mg/kg loading dose and followed by 0.5mg/kg/h during operation
Ketamine
ketamine 0.5mg/kg loading followed by 0.5mg/kg/h infusion during operation
Placebo
normal saline 0.5mg/kg loading dose and followed by 0.5mg/kg/h during operation
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ketamine
ketamine 0.5mg/kg loading followed by 0.5mg/kg/h infusion during operation
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* American Physical Status Classification I or II
Exclusion Criteria
* past history of operation at lumbar area
* past history of glucoma, drug abuse, alcohol abuse
* pregnancy
20 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yonsei University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cholhee Park
Clinical assistant professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kyung Hyun Kim, MD
Role: PRINCIPAL_INVESTIGATOR
Department of Neurosurgery, The Spine and Spinal Cord Institute, Gangnam Severance Spine Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gangnam Severance Hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
3-2014-0062
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.